Introduction
osteoarthritis (oA) is the most common chronic joint disease in the elderly, and it is obesity, osteoarthritis and genetic risk
The RS182052 PolyMoRPhISM IN The ADIPoQ geNe IS PoTeNTIAlly ASSoCIATeD WITh RISk oF kNee oSTeoARThRITIS
Objectives
Given the function of adiponectin (ADIpoQ) on the inflammatory condition of obesity and osteoarthritis (oA), we hypothesized that the ADIpoQ gene might be a candidate gene for a marker of susceptibility to oA.
predicted that it will be the single greatest cause of disa bility in the general population by 2030. 1 Similar increas ing trends in the prevalence of oA are found in China. With ageing populations and a worldwide obesity epi demic, oA is regarded as a global public health issue. Studies show that oA is a multifactorial disease that is influenced by ageing, the environment, genetic predis position and the interactions between them. 26 There is substantial evidence highlighting the relation ship between obesity and oA. 79 however, mechanical loading cannot explain the incidence and progression of oA in nonweightbearing joints such as fingers and wrists. 4, 1012 This suggests probable complex mechanisms linking obesity and oA, including biomechanical, physi ological and inflammatory. 13, 14 Adipose tissue is well rec ognized as an active endocrine organ, releasing various adipokines such as adiponectin (ADIPoQ), leptin and vis fatin, which are involved in complex biological interac tions between fat and other tissues, and play a significant role in bone formation and bone absorption. 15, 16 obesity is one of the strongest predictive and prognostic factors for oA, particularly in knee joints, and, to a lesser extent, the hip. 17 Adiponectin, encoded by the ADIPoQ gene, is a specific protein secreted by adipose tissue. 18 First described in 1995, it has a modular structure consisting of a collagenlike Nterminal domain and a Cterminal globular domain that is similar to tumour necrosis factor alpha (TNFα). 19, 20 Adiponectin is a complex molecule that plays an important role in the regulation of insulin sensitivity and glucose homeostasis, as well as lipid and fatty acid oxidation. 21 ADIPoQ gene expression has been shown to reduce the production of proinflammatory cytokines such as interleukin6, interleukin8 and TNFα, and induce the release of antiinflammatory cytokines. This suggests a contribution to the lowgrade inflamma tory state that exists in obesity. 2224 Recently, ADIPoQ has been found to participate in the inflammatory process, and may trigger articular cartilage injury through the upregulation of cytokines, matrixdegrading enzymes and chemokines in both chondrocytes and synovial fibro blasts. 2527 A recent casecontrolled study reported that the ADIPoQ level positively correlated with disease sever ity in patients with knee oA. 28 ADIPoQ might be consid ered as a potentially effective biomarker for joint damage in oA. 29 The human ADIPoQ gene is located on chromosome 3q27 and spans approximately 17 kb, consisting of three exons and two introns. 30 Previous studies have indicated that the ADIPoQ gene may be identified as a genetic region for phenotypes associated with various diseases, such as obesity, rheumatoid arthritis, diabetes and coro nary heart disease. 3134 however, the study of the rela tionship between ADIPoQ polymorphisms and oA has been limited. 35 obesity may have a shared genetic background with oA based on the wellestablished epidemiological link.
given the role of ADIPoQ in the inflammatory pathophysi ology of obesity and its link to oA, we hypothesized that the ADIPoQ gene expression could modulate the level of ADIPoQ and might potentially be a candidate gene, as a marker for the susceptibility to oA. To the best of our knowledge, no studies on the north east Chinese popula tion about the relationship between ADIPoQ gene vari ants and the risk of oA have been conducted. The objective of this study was to explore several ADIPoQ polymor phisms and investigate their genetic association with the susceptibility to oA among a Chinese population.
Materials and Methods
Study design and participants. A populationbased case controlled study was carried out to evaluate whether the polymorphism of ADIPoQ was associated with knee oA in harbin City in heilongjiang Province, northern China. With the assistance of the local community councils, residents who lived at their registered address during the study period, having permanent living records with Chinese han nationality, were recruited. The participants were 40 years and over, and residents of the hongqi com munity in the Xiangfan metropolitan district, and were recruited using stagestratified sampling methods, and representing the middle standard of life in harbin city. A total of 1636 participants completed a questionnaire and underwent clinical and radiological examination. of these, 110 participants were excluded for the following reasons: no blood sample available (n = 36); no physi cal examination available (n = 29); and no radiological images available (n = 45). The remaining 1526 partici pants were classified into four groups based on their clini cal and radiological knee status: group 1) knee pain with radiologically defined oA (n = 196); group 2) the control group having neither knee pain nor radiological evidence of knee oA (n = 442); group 3) knee pain without oA, i.e. participants with knee pain but without radiologically defined knee oA (n = 195); and group 4) radiologically defined knee oA but without knee pain (n = 693). The oA patients in group 1 had definite symptomatic oA and radiological evidence in at least one knee joint.
The questionnaire was designed to collect data from all participants regarding basic demographics, occupa tion and sporting activities, previous knee injury, family history of oA and rheumatological manifestations.
Clinical symptoms were defined as significant when signs and symptoms of knee pain were present for at least one month's duration during the previous 12 months. The radiological assessment of oA was made using the kellgrenlawrence grading system. 36 knee radiological images were evaluated independently by two experienced radiologists (JR and SW) who were blinded to patient presentation. Consensus was reached whenever results were divergent. Cases where there was uncertainty were recalled and reexamined by a specialist to ensure the validity. The control group had no signs or symptoms of arthritis or joint disease. Patients with a pre vious knee injury and secondary oA, and patients with inflammatory disease or rheumatoid arthritis and devel opmental dysplasia, were excluded. All participants underwent a physical examination, and body mass index (BMI) (weight/height 2 ) was recorded. height was meas ured to the nearest 0.1 cm using a wallmounted stadi ometer. Body weight was measured with a digital scale to the nearest 0.1 kg. The classification of obesity status was defined according to the criteria of the Working group on obesity in China, based on the analysis of data collected from 239 972 Chinese adults in the 1990s: 37 underweight and normal (BMI ⩽ 24.0); overweight (BMI 24.0 to 28.0); and obese (BMI ⩾ 28.0).
The project protocol was reviewed and approved by the ethics Committee of harbin Medical university, and written informed consent was obtained from each participant. Single nucleotide polymorphism (SNP) selection. Public databases of the National Center for Biotechnology Information (NCBI) were used to collect information about SNPs and genes. 38 Based on the hapMap SNP database (phase II + III Feb 09, on NCBI B36 assembly, dbSNP b126) and haploview 4.2 software, 39 common SNPs (minor allele frequency (MAF) ⩾ 5% in the Chinese han population) were screened in ADIPoQ gene regions. The context sequences of SNPs with low linkage disequi librium (lD) analysis (r 2 < 0.8) were retained. As a result, three targeting SNPs (rs182052, rs2082940, rs6773957) were finally selected and further determined to perform genotyping assays. Genotyping assays. Peripheral blood was collected from each subject following informed consent, and genomic DNA from cases and controls was isolated from periph eral blood lymphocytes. genomic DNA was extracted from the samples with a DNA extraction kit (Qiagen Inc, valencia, California). Further DNA concentration measures were obtained using a Nanodrop 2000 spectrophoto meter (ThermoFisher Scientific, Waltham, Massachusetts). Polymerase chain reaction (PCR) was performed in a total reaction volume of 4 μl containing about 10 ng of genomic DNA. The PCR conditions depended on the requirements of each probe according to the manufacturer's indica tions. The genotype of each sample at this stage was per formed using the iPleX Sequenom MassARRAy platform (Sequenom Inc, San Diego, California).
The following series of methods were used to control the quality of genotyping: 1) case and control samples were mixed on each plate; 2) genotyping was performed blinded to case or control status for the clinical person nel; 3) 5% of the samples were randomly selected for repeat genotyping as blind duplicates and the reproduc ibility was 100%. As a quality control measure, we included one sample with no template, and one sample duplicate per 96well plate (a total of four per 384well plate used). SDS 2.3 Allelic Discrimination Software (Applied Biosystems, Foster City, California) was employed to determine genotypes. genotypes were provided auto matically by the software, and then were determined manually by two different people in the laboratory. Statistical analysis. The chisquared test for categorical variables and Student's ttest for continuous variables were used to analyze for differences in demographic characteristics, the selected variables and genotypes between cases and controls. The hardyWeinberg equi librium (hWe) for the distribution of each SNP was evalu ated using the goodnessoffit χ 2 test, by comparing the observed genotype frequencies with the expected ones. genotyperelated odds ratios (oRs), their corresponding 95% confidence intervals (CIs) and associated pvalues were estimated via unconditional logistic regression. This was calculated for an additive model (minor allele homozygotes versus heterozygotes versus major allele homozygotes) with adjustment for age, gender, BMI, occupation and physical activity. An association study is designed specifically to reveal associations that depend additively upon the minor allele. That is, the genotype of the individual that has two minor alleles (variant homo zygote), rather than having no minor alleles (wildtype homozygote), is twice as likely to affect the outcome in a certain direction as just one minor allele (heterozygote) rather than no minor alleles (wildtype homozygote). The Bonferroni correction was used for multiple comparisons, which was a safeguard against multiple tests of statistical significance on the same data. For this study, three tag ging SNPs on the ADIPoQ gene were genotyped, thus the associations between ADIPoQ SNPs and oA risk with p-values < 0.017 (0.05/3) were considered significant after correction for multiple testing. To examine the dif ferences between subgroups, the chisquared (χ 2 )based Qtest was used to test the heterogeneity of effect sizes (oRs and 95% CIs) derived from corresponding sub groups. All pvalues were twosided, and those less than 0.05 were considered statistically significant. STATA (ver sion 13.1; StataCorp, College Station, Texas) was used for all the statistical analyses.
Results
The basic demographic data of the 196 cases in group 1 with symptoms and radiological changes of oA and the 442 controls in group 2 are summarized in Table I . There was no significant difference detected in gender between oA cases and controls (χ 2 = 3.173, p = 0.090). The mean age of cases was significantly higher than that of controls (t = 6.486, p < 0.001). The distribution of BMI among cases and control is significantly different (χ 2 = 8.465, p = 0.015), and oA cases possessed a higher frequency of being overweight (39.29%) and obese (26.02%) com pared with the control group (34.84% overweight and 18.78% obese). In terms of smoking and drinking status, no significant difference was detected between the cases group and the control group (χ 2 = 0.994, p = 0.330 for smoking; χ 2 = 0.1.379, p = 0.254 for drinking). Also, no significant difference was checked for occupation or for physical activity between the cases group and the control group (χ 2 = 1.479, p = 0.224 for occupation; χ 2 = 3.286, p = 0.090 for physical activity).
The results for the three SNPs are shown in Supplementary table i. genotyping success rates for all polymorphisms were greater than 98%, and the observed genotype frequencies for these SNPs in the control group were all in agreement with hWe (p > 0.05). logistic regression analyses were performed for the three SNPs (Table II) . It showed that the variant ADIPoQ rs182052 was potentially associated with oA risk. Those individu als with the genotype gA versus gg and those with gen otype AA compared with gA in rs182052 tended to present a higher risk of oA, and the allele A could increase the oA risk (additive model: oR = 1.38; 95% CI 1.07 to 1.76; p = 0.012). The associations of rs182052 and risk of oA remained significant after correction for multiple testing (n = 3) with p < 0.017. We found no evidence of any significant association between the remaining two SNPs and oA. That is, no statistical differ ence was found between the association of SNP rs2082940 and oA (additive model: oR = 1.16; 95% CI 0.87 to 1.55; p = 0.303), nor SNP rs6773957 and oA (additive model: oR = 1.03; 95% CI 0.80 to 1.33; p = 0.819) (Supplementary table i) . Further evaluation of the association between rs182052 and knee oA was performed using stratification of age and BMI (Table III) . Significant associations between rs182052 and knee oA were found in subjects aged ⩾ 57 years (oR = 1.44; 95% CI 1.07 to 1.93; p = 0.015). Significant associations between rs182052 and knee oA were also detected in subjects with a BMI < 24 (oR = 1.69; 95% CI 1.14 to 2.50; p = 0.009). In addition, no significant heterogeneity was observed among the strati fied subgroups of age and BMI (p = 0.666 and 0.321, respectively).
As well as the above stratification, we further explored genefactor interaction in the identified SNP rs182052. Considering the significant differences in distribution of age and BMI between case and control groups, we fur ther investigated whether the effect of rs182052 on oA risk was modified by age and BMI. Collectively, interac tion analyses failed to detect any significant association between rs182052 and BMI on oA risk (multiple interac tion p = 0.063) ( Table Iv) . That is, among those individu als with BMI < 24, a combination with gA/AA genotype had a higher chance of developing oA (oR = 2.69; 95% CI 1.33 5.42; p = 0.006). Whereas, among those indi viduals with BMI ⩾ 24, a combination with the gg geno type presented a higher chance of developing oA (oR = 3.01; 95% CI 1.43 6.34; p = 0.004), and a combi nation with gA/AA genotype also tended to be more likely to develop oA (oR = 3.59; 95% CI 1.82 7.07; p < 0.001). As for the interaction of identified SNP oBeSITy, oSTeoARThRITIS AND geNeTIC RISk vol. 7, No. 7, July 2018 rs182052 and age on oA risk, the similar pattern of non significant interaction was also detected (multiple inter action p = 0.614) (Supplementary table ii) .
Discussion
osteoarthritis is a complex disease, arising from the inter action of multiple factors including individual genetic factors and environmental factors. epidemiological stud ies have shown a strong genetic component to the sus ceptibility to oA. 2 growing evidence indicates that the release of additional adipokines may be responsible for the increase of oA observed among obese people. 27, 28 obesity might play a critical role in the development and progression of oA. 40 From a pathophysiological perspec tive, there is increasing evidence to suggest that ADIPoQ plays an important role in the onset and progression of oA. 29 In our study, we systematically evaluated the asso ciation of three tagging polymorphisms in the ADIPoQ gene with oA risk in a casecontrolled study of 196 oA cases and 442 controls in a northern Chinese population. The SNP rs182052 was identified to be significantly asso ciated with knee oA susceptibility. however, we found no evidence of significant association between SNP rs2082940, rs6773957 and knee oA risk.
To the best of our knowledge, this is the first study to evaluate the association of several polymorphisms in the ADIPoQ gene and the risk of symptomatic knee oA in an Asian population. For rs182052, the A allele appeared to be one of the risk factors for knee oA in our study. Zhan et al 35 found no statistically significant difference between ADIPoQ rs1501299 expression and knee oA. In a further study, the same authors showed that rs1501299 and rs2241766 of the ADIPoQ gene were not responsible for oA susceptibility among a Thai population. 41 The differ ent results between the Thai studies and our own study population may be due to genetic backgrounds, gender ratios, population substructure and environmental effects. The sample size in our study was larger than in those pre vious studies. Furthermore, other factors such as age, gender, BMI, occupation and physical activity were adjusted for in our study, in order to detect the associa tion between ADIPoQ and knee oA. our study has several strengths. First, we recruited knee oA cases and selected controls from a community which might better represent the whole population and reduce potential selection bias. Second, the focus on welldefined radiological and clinical features allows for a stringent definition of oA in the study group and may allow differences in gene expression to be observed with more certainty. osteoarthritis phenotype defini tions, reflecting different subsets of oA, have been shown to influence the ability to detect genetic associa tions. 42 Third, with our detailed investigation into whether the ADIPoQ gene is associated with oA, we systematically evaluated three different tagging poly morphisms in both knee oA cases and controls; the SNP 182052 polymorphism was identified as being associated with knee oA. however, our study does have limitations. First, oA is a multifactorial disease with a strong genetic component, with various different estimates of influence of genetic factors depending on the joint involved. We only evalu ated the SNP rs182052, rs2082940 and rs6773957 in the ADIPoQ gene and the risk of knee oA. our results cannot be generalized to oA affecting other joints. Second, we only demonstrated an association. We are unable to show causation in terms of how this gene expression influences the process of oA. Third, due to the small sam ple size (a total of 196 oA cases and 442 control sub jects), the statistical power is about 46.5% when detecting an effect size of 1.50 with an α level of 0.05 in relation to the association of the identified SNPs with oA risk, mak ing our study underpowered. Wellconducted larger sample studies are needed to evaluate our findings. given the modest sample size, especially of younger indi viduals (< 57 years), and the low study power, our results should be interpreted with caution.
In conclusion, we have investigated the role of genetic variants in the ADIPoQ gene in knee oA within a north east Chinese population. our results suggest that the variant A allele of rs182052 is associated with an increased risk of knee oA. Further studies are required to validate our findings, and investigate the possible pathophysio logical processes that this gene expression may influence. Further studies could focus on genderspecific mechanisms and the aetiology of knee oA and elucidate whether the ADIPoQ gene could be targeted for future therapeutic strategies.
Supplementary material
Tables showing a summary of the three single nucleotide polymorphisms and interaction between rs182052 genotypes and age on knee osteoarthritis risk.
